Literature DB >> 16355680

Differentiating benign and malignant causes of lymphocytosis in feline bone marrow.

Douglas J Weiss1.   

Abstract

Differentiation of benign and malignant causes of lymphocytosis in blood or bone marrow can be problematic. In the present study, reports of examinations of bone marrow from cats, submitted over an 8-year period, were reviewed to identify cats with increased numbers of small lymphocytes. Of 203 reports reviewed, 12 (5.9%) indicated increased numbers of small lymphocytes. Diagnoses for these cats included chronic lymphocytic leukemia (CLL; n = 2), pure red cell aplasia (PRCA; n = 4), immune-mediated hemolytic anemia (IMHA; n = 3), thymoma (n = 1), cholangiohepatitis (n = 1), and fever of unknown origin (n = 1). Several factors were identified that could be used to differentiate reactive lymphocytosis from CLL. Cats with CLL tended to be older, and lymphocytes were slightly larger and had cleaved or lobulated nuclei. Reactive lymphocytosis was associated with immune-mediated anemias and inflammatory diseases. In reactive lymphocytosis, the proliferating lymphocytes were organized into lymphoid aggregates in bone marrow and were predominately B cells. Alternatively, in CLL and thymoma, the proliferating lymphocytes were diffusely distributed and were predominately T cells. Therefore, differentiation of the causes of lymphocytosis should include evaluation of signalment, concurrent disease conditions, lymphocyte morphology, lymphocyte distribution in bone marrow, and immunophenotype. Cat age, presence of severe anemia, and evidence of inflammatory disease also should be considered.

Entities:  

Mesh:

Year:  2005        PMID: 16355680     DOI: 10.1892/0891-6640(2005)19[855:dbamco]2.0.co;2

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  5 in total

1.  Immunophenotypic characterization and clinical outcome in cats with lymphocytosis.

Authors:  Emily D Rout; Julia D Labadie; Kaitlin M Curran; Janna A Yoshimoto; Anne C Avery; Paul R Avery
Journal:  J Vet Intern Med       Date:  2019-11-06       Impact factor: 3.333

2.  2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1- Defining populations at risk.

Authors:  Armelle deLaforcade; Lenore Bacek; Marie-Claude Blais; Corrin Boyd; Benjamin M Brainard; Daniel L Chan; Stefano Cortellini; Robert Goggs; Guillaume L Hoareau; Amy Koenigshof; Ron Li; Alex Lynch; Alan Ralph; Elizabeth Rozanski; Claire R Sharp
Journal:  J Vet Emerg Crit Care (San Antonio)       Date:  2022-05-02

3.  Demographic Characteristics, Survival and Prognostic Factors for Mortality in Cats with Primary Immune-Mediated Hemolytic Anemia.

Authors:  J W Swann; B Szladovits; B Glanemann
Journal:  J Vet Intern Med       Date:  2015-12-09       Impact factor: 3.333

Review 4.  The feline acute phase reaction.

Authors:  Saverio Paltrinieri
Journal:  Vet J       Date:  2007-08-07       Impact factor: 2.688

5.  Presumptive precursor-targeted immune-mediated anemia concurrent with gastrointestinal lymphoma in a cat.

Authors:  Makoto Akiyoshi; Masaharu Hisasue; Sakurako Neo; Masami Akiyoshi
Journal:  J Vet Med Sci       Date:  2020-08-28       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.